Literature DB >> 27796476

Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.

Luise Burkhardt1,2, Stephan Lobitz1, Elisabeth Koustenis1,3, Stefan Mark Rueckriegel1,4, Pablo Hernáiz Driever5.   

Abstract

Cerebrovascular disease is an important feature of pediatric sickle cell disease (SCD) and may lead to cognitive and motor impairment. Our cross-sectional study examined the incidence and severity of these impairments in a pediatric cohort without clinical cerebrovascular events from Berlin of mixed ethnic origin. Thirty-two SCD patients (mean age 11.14 years, range 7.0-17.25 years; males 14) were evaluated for full-scale intelligence (IQ) (German version WISC-III), fine motor function (digital writing tablet), and executive function (planning, attention, working memory, and visual-spatial abilities) with the Amsterdam Neuropsychological Tasks (ANT) program and the Tower of London (ToL). Data on clinical risk factors were retrieved from medical records. Full-scale IQ of patients was preserved, whereas performance IQ was significantly reduced (91.19 (SD 12.17) d = 0.7, p = 0.007). SCD patients scored significantly lower than healthy peers when tested for executive and fine motor functions, e.g., planning time in the ToL (6.73 s (SD 3.21) vs. 5.9 s in healthy peers (SD 2.33), d = 0.5, p = <0.001) and frequency on the writing tablet (mean z score -0.79, d = 0.7, p < 0.001). No clinical risk factors were significantly associated with incidence and severity of cognitive and motor deficits. Despite the preservation of full-scale IQ, our SCD cohort of mixed origin exhibited inferior executive abilities and reduced fine motor skills. Our study is limited by the small size of our cohort as well as the lack for control of sociodemographic and socioeconomic factors modulating higher functions but highlights the need for early screening, prevention, and specific interventions for these deficits.

Entities:  

Keywords:  Attention; Cerebral infarcts/cerebrovascular disease; Children; Fine motor function; Intelligence; Sickle cell disease

Mesh:

Year:  2016        PMID: 27796476     DOI: 10.1007/s00277-016-2861-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease.

Authors:  Anna M Hood; Allison A King; Melanie E Fields; Andria L Ford; Kristin P Guilliams; Monica L Hulbert; Jin-Moo Lee; Desiree A White
Journal:  Pediatr Blood Cancer       Date:  2019-07-03       Impact factor: 3.167

2.  Associations of transcranial doppler velocity, age, and gender with cognitive function in children with sickle cell anemia in Nigeria.

Authors:  Kemar V Prussien; Auwal Salihu; Shehu U Abdullahi; Najibah A Galadanci; Khadija Bulama; Raymond O Belonwu; Fenella J Kirkham; Janet Yarboi; Heather Bemis; Michael R DeBaun; Bruce E Compas
Journal:  Child Neuropsychol       Date:  2018-10-01       Impact factor: 2.500

3.  Neurocognitive functioning in preschool children with sickle cell disease.

Authors:  Andrew M Heitzer; Diana L Cohen; Victoria I Okhomina; Ana Trpchevska; Brian Potter; Jennifer Longoria; Jerlym S Porter; Jeremie H Estepp; Allison King; Misham Henley; Guolian Kang; Jane S Hankins
Journal:  Pediatr Blood Cancer       Date:  2021-12-31       Impact factor: 3.838

4.  The impact of sickle cell anemia on the quality of life of sicklers at school age.

Authors:  Karimeldin M A Salih
Journal:  J Family Med Prim Care       Date:  2019-02

5.  Season of birth and sugary beverages are predictors of Raven's Standard Progressive Matrices Scores in adolescents.

Authors:  Reem Al-Sabah; Abdullah Al-Taiar; Abdur Rahman; Lemia Shaban; Anwar Al-Harbi; Olusegun Mojiminiyi
Journal:  Sci Rep       Date:  2020-04-09       Impact factor: 4.379

6.  Mapping of long-term cognitive and motor deficits in pediatric cerebellar brain tumor survivors into a cerebellar white matter atlas.

Authors:  Frederik Grosse; Stefan Mark Rueckriegel; Ulrich-Wilhelm Thomale; Pablo Hernáiz Driever
Journal:  Childs Nerv Syst       Date:  2021-08-05       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.